A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
In dogs, melanomas are relatively common tumors and the most common form of oral malignancy. Biological behavior is highly variable, usually aggressive, and frequently metastatic, with reported survival times of three months for oral or mucosal melanomas in advanced disease stages. Classical clinica...
Main Authors: | Ramón M. Almela, Agustina Ansón |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/6/1/15 |
Similar Items
-
COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour
by: Tatiany L. Silveira, et al.
Published: (2021-08-01) -
An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy
by: Nuša Brišar, et al.
Published: (2024-02-01) -
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
by: Lidia Tarone, et al.
Published: (2022-02-01) -
A Comparative View on Molecular Alterations and Potential Therapeutic Strategies for Canine Oral Melanoma
by: Laura Hardwick
Published: (2021-11-01) -
Comparative Aspects of Canine Melanoma
by: Adriana Tomoko Nishiya, et al.
Published: (2016-02-01)